Genus PLC
06 August 2003
6 August 2003
GENUS plc
Board Change
Genus plc ('Genus' or the 'Group'), the international bovine genetics company,
announces today that Michael Roller, Group Finance Director, will leave the
Group with effect from today to pursue other opportunities.
Philip Acton, currently Chief Operating Officer of the Animal Health division,
having moved only recently to this broader managerial role from Group Finance
Director, will re-assume the role of Group Finance Director for an interim
period until a replacement is found. The Board has commenced the search for a
new Group Finance Director.
Richard Wood, Chief Executive of Genus, said:
'We thank Michael for his contribution to Genus and wish him well for the
future. We are actively seeking a suitable permanent replacement for Michael. An
announcement will be made in due course. Philip has considerable experience in
handling the Group's finances having been Group Finance Director since 1995.'
Contacts:
Genus plc
Richard Wood, Chief Executive Tel: 01256 347 100
Philip Acton Tel: 01904 487 404
Buchanan Communications Limited Tel: 020 7466 5000
Charles Ryland / Catherine Miles
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.